CencoraCOR

NYSE · USA · Segment 8 of 8 in the Medicine, pharma & life science value chain: Distribution & pharmacy infrastructure

Known as AmerisourceBergen until the rebrand, Cencora distributes medicines and specialty drugs to the healthcare sector and sells services to pharmacies.

Distribution & pharmacy infrastructure: Wholesalers, distribution and pharmacy chains that get medicines to patients.

Key metrics

Market cap

$59.2B

Price

$323.77

Today

+1.8%

Return YTD

−5.8%

Return 1Y

+4.9%

P/E

22.5

P/S

0.2

P/B

19.4

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

DistributionWholesalerSpecialty drugsPharmacy infrastructure

In the value chain

Products & services

Drug distribution
Specialty drug distribution
Pharmacy services

Competitors

Risks

Low-margin business
Opioid-related settlements

Supply chain

Supplies →

The Cigna GroupCI

← Suppliers

Alnylam PharmaceuticalsALNY IncyteINCY BioMarin PharmaceuticalBMRN Merck & Co.MRK AmgenAMGN AbbVieABBV Gilead SciencesGILD Eli LillyLLY PfizerPFE Johnson & JohnsonJNJ Bristol Myers SquibbBMY

Full supply chain for COR →

Same segment: Distribution & pharmacy infrastructure

UnitedHealthUNH CVS HealthCVS McKessonMCK The Cigna GroupCI Cardinal HealthCAH

Compare COR

COR vs UNH COR vs CVS COR vs MCK COR vs CI COR vs CAH

See where Cencora sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →